Breakthrough computational tool enhances design of targeted antiviral therapies

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

Cresco Labs Q1 Revenue Falls 5%

Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results Over 10x year-over-year increase in operating cash flow CHICAGO–(BUSINESS WIRE)– Cresco

May 15, 2024

Risk adjusted net present value: What is the current valuation of F. Hoffmann-La Roche’s Basmisanil?

Basmisanil is a small molecule commercialized by F. Hoffmann-La Roche, with a leading Phase II program in Dup15q Syndrome.

November 20, 2023

Healthcare veteran Glen Tullman thinks AI implementation will define health tech in 2025

While there’s already plenty of AI in healthcare that focuses on administrative tasks on the back end, it’s time for AI in health consumer-facing products

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.